NEUMORA THERAPEUTICS, INC. (NMRA) Free cash flow 2023–2024
NEUMORA THERAPEUTICS, INC. (NMRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$183.1MFY2024 · since FY2023: -$163.8M → -$183.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$183.1M | -11.8% |
| FY2023 | -$163.8M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NMRA financial trends
NMRA RevenueNMRA Net incomeNMRA Net marginNMRA Gross profitNMRA Gross marginNMRA Operating incomeNMRA Operating marginNMRA Operating cash flowNMRA Capital expendituresNMRA Return on equityNMRA Stock buybacksNMRA Dividends paidNMRA Total assetsNMRA Total liabilitiesNMRA Shareholders’ equityNMRA overview →